Pregnancy and Congenital Toxoplasmosis

NCT05774496 — Completed, 76 participants, Hospices Civils de Lyon

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Pregnancy and Congenital Toxoplasmosis : Maternal and Child Risks Assessment, Data From Patients Followed-up in the Lyon Cohort

RegistryNCT05774496, acronym GRETA
StatusCompleted
Study typeObservational
Enrollment76 (Actual)
SponsorHospices Civils de Lyon (Other)
ConditionsCongenital Toxoplasmosis, Retinochoroiditis
InterventionsEstimation of the occurrence of retinochoroiditis in women with congenital toxoplasmosis and previous retinochoroiditis lesions (recurrence) during pregnancy and postpartum. (Other)
Datesstart 2023-05-10, primary completion 2024-03-16, completion 2024-03-16, first posted 2023-03-17, last updated 2026-01-22
Locations1 site in France

Related Papers Related Patents Related Grants Related Experts
All trials for Congenital Toxoplasmosis All trials for Retinochoroiditis All trials of Estimation of the occurrence of retinochoroiditis in women with congenital toxoplasmosis and previous retinochoroiditis lesions (recurrence) during pregnancy and postpartum.

-Summary

The Toxoplasma gondii parasite causes toxoplasmosis. It is characterized by persistent cysts mostly localised in the brain and ocular areas. In the case of immunodeficiency, those cysts are likely to reactivate. During pregnancy, an infection exposes the foetus to a variety of consequences, from severe neurologic lesions to subclinical forms at birth. However, those forms are likely to complicate at any age to toxoplasmic retinochoroiditis, that can unpredictably recur with severe functional consequences. Pregnancy may stimulate lesions or their recurrences, putting the foetus at risk of contamination because of the release of tachyzoites in the bloodstream. The occurrence of these complications is poorly known, especially with congenital toxoplasmosis. Nevertheless, this information is essential to take care of patients, particularly women with congenital toxoplasmosis, usually worried about the consequences of a pregnancy.

As a precaution, women with congenital toxoplasmosis follow a specific ophthalmologic, and trimonthly monitoring, composed of fundus examinations during pregnancy and in postpartum. To eliminate the contamination risk, serological examinations at birth and one year later are done on their kids.

The aim of this study is to estimate the risk of toxoplasmic retinochoroiditis during pregnancy and the impact on their children. Retrospective and prospective data from the Lyon Cohort of Maternal and Congenital Toxoplasma Infections will be used.

As a result of to this study, the investigators expect to provide better information to women suffering from congenital toxoplasmosis about their own ocular safety during pregnancy, and the safety of their child(ren). The investigators seek to provide new national and international recommendations about these patients and their children's care.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Congenital toxoplasmosis womenOther: Estimation of the occurrence of retinochoroiditis in women with congenital toxoplasmosis and previous retinochoroiditis lesions (recurrence) during pregnancy and postpartum.Women older than 21 suffering from congenital toxoplasmosis, with or without children.
  • Estimation of the occurrence of retinochoroiditis in women with congenital toxoplasmosis and previous retinochoroiditis lesions (recurrence) during pregnancy and postpartum. (Other): All fundus examinations completed during pregnancy and postpartum in women with congenital toxoplasmosis and previous retinochoroiditis lesions are going to be checked.

+Outcome measures

Primary outcomes

  • The number of toxoplasmic retinochoroiditis during pregnancy in women with congenital toxoplasmosis and previous retinochoroiditis lesions (recurrence). [Toxoplasmic retinochoroiditis that occured during pregnancy (up to 40 weeks)]: All fundus examinations completed during pregnancy in women with congenital toxoplasmosis and previous retinochoroiditis lesions are going to be checked. The occurrence of retinochoroiditis during pregnancy will be compared to the occurrence of toxoplasmic retinochoroiditis during periods without pregnancy.
  • The number of toxoplasmic retinochoroiditis during postpartum in women with congenital toxoplasmosis and previous retinochoroiditis lesions (recurrence). [Toxoplasmic retinochoroiditis that occured during postpartum (up to 6 months after the delivery)]: All fundus examinations completed during postpartum in women with congenital toxoplasmosis and previous retinochoroiditis lesions are going to be checked. The occurrence of retinochoroiditis during postpartum will be compared to the occurrence of toxoplasmic retinochoroiditis during periods without pregnancy.

+Eligibility

Sex: Female, ages: 21 Years to 50 Years

Inclusion Criteria:

* Being a woman
* Born before March 2022
* Suffering from congenital toxoplamosis

Exclusion Criteria:

* Refusal to give informed consent
* Any condition that would limit the ability of the patient to give consent
* Psychiatric cares
* To be deprived of liberty
* To be under administrative supervision

+Locations (1)

FacilityCityCountryStatus
Service de parasitologie et mycologie médicaleLyonFrance

+Investigators

  • Martine Wallon, Principal investigator, Service de parasitologie et mycologie médicale de l'Hôpital de la Croix-Rousse